» Articles » PMID: 15542899

Practical Methods for Tissue Microarray Construction

Overview
Journal Methods Mol Med
Specialty Molecular Biology
Date 2004 Nov 16
PMID 15542899
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

The tissue microarray (TMA) of Kononen et al. is an extension of an idea originally developed by Battifora and consists of an array of cylindrical cores of paraffin-embedded tissue that are removed from preexisting "donor" paraffin blocks. The donor block is a standard tissue block that may be from surgical pathology, autopsy, or research material. A morphologically representative area of interest within the donor block is identified under the microscope using a stained section (usually hematoxylin and eosin stained) on a glass slide as a guide. The tissue cores are removed from the donor and inserted into a "recipient" paraffin block usually using a custom patented instrument from Beecher Instruments. Using a precise spacing pattern, tissues are inserted at high density, with up to 1000 tissue cores in a single paraffin block. Sections from this block that are cut with a microtome are placed onto standard slides that can then be used for in situ analysis. Depending on the overall depth of tissue remaining in the donor blocks, tissue arrays can generate between 100 and 500 sections. Once constructed tissue microarrays can be used with a wide range of techniques including histochemical staining, immunohistochemical/immunofluorescent staining, or in situ hybridization for either DNA or mRNA. In this chapter we present methods of TMA construction with emphasis on providing detailed tips and techniques.

Citing Articles

LRRC25 Is a Potential Biomarker for Predicting Immunotherapy Response in Patients with Gastric Cancer.

Yang Z, Yu B, Hu J, Jiang L, Jian M Dig Dis Sci. 2025; .

PMID: 39961962 DOI: 10.1007/s10620-025-08882-7.


BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma.

Xu D, Gao Y, Yang H, Spils M, Marti T, Losmanova T JTO Clin Res Rep. 2024; 5(5):100672.

PMID: 38715965 PMC: 11070913. DOI: 10.1016/j.jtocrr.2024.100672.


Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model.

Lim S, Kwak M, Kang J, Cesaire M, Tang K, Robey R Acta Neuropathol Commun. 2024; 12(1):56.

PMID: 38589905 PMC: 11003129. DOI: 10.1186/s40478-024-01763-6.


TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis.

Hao X, Lv Y, Li D, Bai F, Gong J, Pan G J Transl Med. 2024; 22(1):6.

PMID: 38167440 PMC: 10763294. DOI: 10.1186/s12967-023-04721-3.


High expression of Talin-1 is associated with tumor progression and recurrence in melanoma skin cancer patients.

Rezaie Y, Fattahi F, Mashinchi B, Kamyab Hesari K, Montazeri S, Kalantari E BMC Cancer. 2023; 23(1):302.

PMID: 37013489 PMC: 10069040. DOI: 10.1186/s12885-023-10771-z.